Placebo to BI 1026706
Sponsors
Boehringer Ingelheim
Conditions
HealthyOsteoarthritis
Phase 1
Effectiveness of Two Different Doses of BI 1026706 on the Overall Peak-to-Peak (PtP) N2/P2-component Amplitude of Laser (Somatosensory, Radiant-heat) Evoked Potentials (LEP) in UVB(Ultraviolet)-Irradiated Skin in Healthy Male Volunteers
CompletedNCT02037165
Start: 2014-01-21End: 2014-04-15Updated: 2019-07-05
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1026706 in Male and Female Healthy Subjects and Patients With Osteoarthritis of the Knee
CompletedNCT02126826
Start: 2014-05-28End: 2014-10-21Updated: 2019-03-25